*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients
*
5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence
54321
Properly diagnose and manage primary and metastatic brain tumors?
Apply targeted agents, immunotherapy and novel technologies to treat gliomas?
*
Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied
54321
Leverging Molecular Signautres to Guide Treatment of Ependymoma - Stephen Mack, Ph.D.
Clinical Implications of Molecular Profiling of Brain Metastases - Priscilla Brastianos, M.D.
Clinical Implicaitnos of Molecular Profiling of Gliomas - Patrick Wen, M.D.
Primary CNS Lymphoma - Fabio Iwamoto, M.D.
Advances in the Mangement of Craniopharyngiomas - Priscilla Brastianos, M.D.
Application of Advanced Tractography and Functional Network for Glioma Surgery - Michael McDermott, M.D.
Systemic Targeted Therapies should Replace SRS for Brain Metasteses - Manmeet Ahluwalia, M.D. (Pro) Veronica Chiang, M.D.
ALL GBM's Should be Treated with TT fields - Roger Stupp (Pro) Patrick Wen, M.D.
Managing Brain Metasteses After SRS: All patients should salvage SRS - Rupesh Kotecha, M.D. (Pro) Vinai Gondi, M.D. (Con)
Clincal Trials of Surgical Immunotherapy for Glioblastoma - Anotonio Chiocca, M.D.
Advances in the Management of Peditatric Brain Tumors - Proton Radiation for All - Matthew Hall, M.D.
*
*
*
*
*
*
Choose 1 option
*
Hours attended